Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 678 of 6351
-
New heart ablation technique targets hidden drivers of AFib
Disease control Recruiting nowThe mechanisms that maintain persistent atrial fibrillation (AF) in humans remain unknown. In the research project PI18/01268 funded in the previous call for Strategic Action in Health, the group has demonstrated that the hierarchical organization of (i) rotational domains, (ii) …
Sponsor: Hospital San Carlos, Madrid • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
AI eye for colonoscopy: could software catch what doctors miss?
Diagnosis CompletedThis completed retrospective study evaluated the clinical performance of ENAD-CADx-01, an artificial intelligence-based medical device software intended to assist healthcare professionals in characterizing colorectal lesions in colonoscopy images. Previously collected colonoscopy…
Sponsor: Ainex Corporation • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
Can a diabetes drug protect the heart after a massive attack?
Disease control Recruiting nowThe goal of this clinical trial is to assess the safety and efficacy of SGLT2i in limiting infarct size in patients with STEMI referred for PPCI. Eligible STEMI patients enrolled into the trial will be randomized to a SGLT2i or placebo. Cardiovascular Magnetic Resonance (CMR) i…
Phase 3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a few doses of ketamine help both depression and alcohol addiction?
Disease control Recruiting nowThe goal of this clinical trial is to investigate the effects of ketamine, in combination with standard inpatient addiction therapy, for adults with depression and alcohol use disorder. After screening and enrollment, participants will undergo baseline assessments of depression, …
Phase 1/2 • Sponsor: University Hospital of North Norway • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug aimed at Hard-to-Treat lung cancer enters Mid-Stage trial
Disease control Recruiting nowCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. The purpose of this study is to assess how safe telisotuzumab vedo…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a water barrier make microwave ablation safer for the womb?
Disease control OngoingThis study aims to compare the safety and efficacy of segmental power adjustment combined with uterine cavity hydro-isolation in microwave ablation of adenomyosis
Sponsor: Peking University Aerospace Center Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Psychedelic drug could lift spirits in final years
Symptom relief Recruiting nowThis multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).
Phase 2 • Sponsor: Charles S. Grob, M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Virtual reality may turn a scary thyroid biopsy into a calmer experience
Symptom relief CompletedThyroid nodules are a common health problem in the adult population. Ultrasound-guided fine-needle aspiration biopsy (FNAB) is the standard diagnostic procedure for evaluating suspected thyroid nodules. Although FNAB is generally considered a safe and minimally invasive procedure…
Sponsor: Dicle University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can a handheld scanner find brain bleeds faster on the battlefield?
Diagnosis CompletedThe Infrascanner model 2500 is a handheld, noninvasive device that is FDA-cleared to detect traumatic intracranial hematomas. FDA clearance K200203 was issued in 2020, K211617 added pediatric age group to the IFU in 2022, and K241389 approved higher laser power use to address dar…
Sponsor: InfraScan, Inc. • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
One-shot gene therapy aims to shrink ear tumors without surgery
Disease control Recruiting nowThis trial will evaluate the safety and tolerability of a single unilateral administration of one of three dose levels of AAVAnc80-antiVEGF and will evaluate the Akouos delivery device to safely achieve the intended product performance.
Phase 1/2 • Sponsor: Akouos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy shows promise for Hard-to-Treat breast cancer
Disease control OngoingThe WIN-B is an international, multicenter, single-arm, phase Ib/II study to evaluate the safety and activity of the Debio 0123 and Sacituzumab govitecan combination therapy in patients with pre-treated advanced/metastatic TNBC or HR+/HER2- breast cancer. Phase Ib will explore if…
Phase 1/2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo therapy aims to keep stomach cancer from coming back after surgery
Disease control Recruiting nowThis study is a prospective, single-arm, phase II clinical study. Screening patients with stage III GC/GEJ adenocarcinoma after D2 or broader radical resection. After enrolling in the study, the subjects receive Sintilimab combined with oxaliplatin+Tegafur, Gimeracil and Oteracil…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for hard-to-treat ovarian cancer: combo therapy enters human trial
Disease control Recruiting nowThis trial was designed as a single-arm, open-label, prospective clinical trial to evaluate the efficacy (ORR) and safety (AE incidence) of CapsuleX in combination with cisplatin for platinum-resistant recurrent ovarian cancer (PROC).
Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug combo aims to fight Hard-to-Treat cancers
Disease control Recruiting nowPhase IIa study of HX009+ IN10018 in combination with or without standard chemotherapy in patients with advanced solid tumours including biliary tract malignancies and malignant melanoma
Phase 1/2 • Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug aims to reduce kidney damage in chronic disease
Disease control OngoingThis study is a multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial designed to investigate the efficacy and safety of different doses of sal0120 tablets in patients with CKD.
Phase 2 • Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can a wearable sensor beat Finger-Prick tests for type 2 diabetes?
Disease control OngoingThe clinical value of CGM for diabetic patients undergoing insulin therapy has been widely recognized, but the evidence-based support for its use in non-insulin-treated type 2 diabetic patients remains insufficient. The primary objective of this study is to evaluate the effect of…
Sponsor: Sinocare • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New pill aims to slow Parkinson's in genetically targeted patients
Disease control Recruiting nowThe goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based…
Phase 2 • Sponsor: Neuron23 Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a vaccine teach the immune system to fight HER2-Positive tumors?
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of vaccine therapy in treating patients with metastatic solid tumors. Vaccines made from antibodies and peptides combined with tumor cells may help the body build an effective immune response to kill tumor cells.
Phase 1 • Sponsor: Pravin T.P Kaumaya • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a glowing dye help surgeons see and remove bladder cancer more completely?
Diagnosis Recruiting nowBladder cancer ranks as the fourth most common malignancy among males the United States . Approximately 75% of patients present with non-muscle-invasive bladder cancer (NMIBC). For the diagnosis and treatment of NMIBC, current guidelines widely recommend white light cystoscopy (W…
Sponsor: Yunnan Cancer Hospital • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
New transplant strategy aims to stop lymphoma from spreading to the brain
Prevention Recruiting nowA serious consequence of systemic diffuse large B-cell lymphoma (DLBCL) is secondary central nervous system (CNS) relapse, which occurs in approximately 5% of all patients. Many CNS relapses occur within the first year after completion of frontline treatment and are associated wi…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Aug 30, 2026 00:00 UTC